T.H. v. Novartis
Ninety percent of the prescription drugs consumed in the United States are generic forms of brand-name drugs. But under U.S. Supreme Court case law, generic drug companies can’t be sued for failing to warn consumers of the dangers of their drug, no matter how inadequate the label may be. Public Justice was lead counsel before…